DMEMEDS shared post via Reuters: Medtronic settles heart valve patent fight with rival Edwards

(Reuters) - Medtronic Inc agreed to pay more than $1 billion to rival Edwards Lifesciences Corp to settle patent litigation and keep its CoreValve artificial heart valve on the U.S. market. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/u62x7UMNBog/story01.htm

Read More